| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
SIG Stock Overview
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale and distribution of pharmaceutical products primarily in Australia.
Sigma Healthcare Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.47 |
| 52 Week High | AU$0.69 |
| 52 Week Low | AU$0.42 |
| Beta | -0.13 |
| 1 Month Change | -12.04% |
| 3 Month Change | 1.06% |
| 1 Year Change | -30.15% |
| 3 Year Change | -6.86% |
| 5 Year Change | n/a |
| Change since IPO | -63.32% |
Recent News & Updates
Shareholder Returns
| SIG | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 0.5% | 0.9% | 0.6% |
| 1Y | -30.1% | -1.6% | 6.7% |
Return vs Industry: SIG underperformed the Australian Healthcare industry which returned -1.6% over the past year.
Return vs Market: SIG underperformed the Australian Market which returned 6.7% over the past year.
Price Volatility
| SIG volatility | |
|---|---|
| SIG Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 9.6% |
| 10% most volatile stocks in AU Market | 16.6% |
| 10% least volatile stocks in AU Market | 4.4% |
Stable Share Price: SIG is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: SIG's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1912 | n/a | Vikesh Ramsunder | https://www.sigmahealthcare.com.au |
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale and distribution of pharmaceutical products primarily in Australia. It operates approximately 1,200 branded and independent pharmacy stores under the Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave brands. The company also provides hospital pharmacy wholesale services; dose administration aid services to the aged care sector, community pharmacy sector, and in the home; technology solutions and data analytics; and product development and support for a range of private and exclusive label products, as well as supplies medical consumables and devices to a broad range of customers, including pharmacy aged care facilities, hospitals, and clinics.
Sigma Healthcare Fundamentals Summary
| SIG fundamental statistics | |
|---|---|
| Market Cap | AU$464.71m |
| Earnings (TTM) | -AU$7.24m |
| Revenue (TTM) | AU$3.45b |
0.1x
P/S Ratio-64.2x
P/E RatioIs SIG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIG income statement (TTM) | |
|---|---|
| Revenue | AU$3.45b |
| Cost of Revenue | AU$3.22b |
| Gross Profit | AU$227.11m |
| Other Expenses | AU$234.35m |
| Earnings | -AU$7.24m |
Last Reported Earnings
Jan 31, 2022
Next Earnings Date
Sep 22, 2022
| Earnings per share (EPS) | -0.0073 |
| Gross Margin | 6.59% |
| Net Profit Margin | -0.21% |
| Debt/Equity Ratio | 36.9% |
How did SIG perform over the long term?
See historical performance and comparisonDividends
4.3%
Current Dividend Yield-273%
Payout RatioValuation
Is Sigma Healthcare undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: SIG (A$0.48) is trading below our estimate of fair value (A$1.88)
Significantly Below Fair Value: SIG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: SIG is unprofitable, so we can't compare its PE Ratio to the Australian Healthcare industry average.
PE vs Market: SIG is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SIG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SIG is good value based on its PB Ratio (1x) compared to the AU Healthcare industry average (2x).
Future Growth
How is Sigma Healthcare forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
67.2%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SIG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).
Earnings vs Market: SIG is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SIG's is expected to become profitable in the next 3 years.
Revenue vs Market: SIG's revenue (3% per year) is forecast to grow slower than the Australian market (5.1% per year).
High Growth Revenue: SIG's revenue (3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SIG's Return on Equity is forecast to be low in 3 years time (6.9%).
Past Performance
How has Sigma Healthcare performed over the past 5 years?
-23.3%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SIG is currently unprofitable.
Growing Profit Margin: SIG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SIG is unprofitable, and losses have increased over the past 5 years at a rate of 23.3% per year.
Accelerating Growth: Unable to compare SIG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SIG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (35.6%).
Return on Equity
High ROE: SIG has a negative Return on Equity (-1.3%), as it is currently unprofitable.
Financial Health
How is Sigma Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: SIG's short term assets (A$761.6M) exceed its short term liabilities (A$457.6M).
Long Term Liabilities: SIG's short term assets (A$761.6M) exceed its long term liabilities (A$301.9M).
Debt to Equity History and Analysis
Debt Level: SIG's net debt to equity ratio (30.5%) is considered satisfactory.
Reducing Debt: SIG's debt to equity ratio has increased from 6.3% to 36.9% over the past 5 years.
Debt Coverage: SIG's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: SIG's interest payments on its debt are not well covered by EBIT (0.4x coverage).
Balance Sheet
Dividend
What is Sigma Healthcare current dividend yield, its reliability and sustainability?
4.26%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SIG's dividend (4.26%) is higher than the bottom 25% of dividend payers in the Australian market (2.42%).
High Dividend: SIG's dividend (4.26%) is low compared to the top 25% of dividend payers in the Australian market (5.66%).
Stability and Growth of Payments
Stable Dividend: SIG's dividend payments have been volatile in the past 10 years.
Growing Dividend: SIG's dividend payments have fallen over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: SIG is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: SIG is paying a dividend but the company has no free cash flows.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
0.5yrs
Average management tenure
CEO
Vikesh Ramsunder (50 yo)
0.17
Tenure
Mr. Vikesh Ramsunder, B.Com, MBL, has been Chief Executive Officer and Managing Director of Sigma Healthcare Limited since February 01, 2022 and serves as its Director since February 17, 2022. He served as...
Leadership Team
Experienced Management: SIG's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.
Board Members
Experienced Board: SIG's board of directors are considered experienced (6.2 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Sigma Healthcare Limited's employee growth, exchange listings and data sources
Key Information
- Name: Sigma Healthcare Limited
- Ticker: SIG
- Exchange: CHIA
- Founded: 1912
- Industry: Health Care Distributors
- Sector: Healthcare
- Implied Market Cap: AU$464.707m
- Shares outstanding: 988.74m
- Website: https://www.sigmahealthcare.com.au
Location
- Sigma Healthcare Limited
- 3 Myer Place
- Rowville
- Victoria
- 3178
- Australia
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/04/18 00:00 |
| End of Day Share Price | 2022/04/14 00:00 |
| Earnings | 2022/01/31 |
| Annual Earnings | 2022/01/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.